Cargando…
Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab
BACKGROUND: The link between immediate hypersensitivity reactions (HSR) following the first cetuximab infusion and the IgE sensitization against anti-galactose-α-1,3-galactose (α-Gal) is now well-established. An automated Fluoroenzyme-Immunoassay (FEIA) is available and may facilitate the screening...
Autores principales: | Serrier, Julien, Davy, Jean-Baptiste, Dupont, Benoît, Clarisse, Bénédicte, Parienti, Jean-Jacques, Petit, Gautier, Khoy, Kathy, Ollivier, Yann, Gervais, Radj, Mariotte, Delphine, Le Mauff, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827640/ https://www.ncbi.nlm.nih.gov/pubmed/36624467 http://dx.doi.org/10.1186/s12885-023-10501-5 |
Ejemplares similares
-
Case Report About Fatal or Near-Fatal Hypersensitivity Reactions to Cetuximab: Anticetuximab IgE as a Valuable Screening Test
por: Dupont, Benoît, et al.
Publicado: (2014) -
Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves’ disease
por: Villalta, Danilo, et al.
Publicado: (2018) -
Galactose-ƒ¿-1,3-galactose (ƒ¿-gal)-specific IgE test is highly useful for predicting cetuximab-induced anaphylaxis
por: Morita, Eishin, et al.
Publicado: (2014) -
Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring
por: Khoy, Kathy, et al.
Publicado: (2020) -
Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection
por: Park, Kyung Hee, et al.
Publicado: (2021)